ArticleFrontiers in immunology2026

Extracellular vesicles as prognostic biomarkers: results of a neoadjuvant chemoimmunotherapy clinical trial in stage IIIA (N2) non-small-cell lung cancer (SAKK 16/14).

Yannik da Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.